Advertisement
Review Article| Volume 38, ISSUE 4, P595-605, December 2018

Human Leukocyte Antigen Epitope Matching in Solid Organ Transplantation

Published:October 05, 2018DOI:https://doi.org/10.1016/j.cll.2018.07.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Terasaki P.I.
        • Ozawa M.
        Predicting kidney graft failure by HLA antibodies: a prospective trial.
        Am J Transplant. 2004; 4: 438-443
        • Tait B.D.
        • Susal C.
        • Gebel H.M.
        • et al.
        Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
        Transplantation. 2013; 95: 19-47
        • Wiebe C.
        • Nickerson P.
        Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.
        Curr Opin Organ Transplant. 2013; 18: 470-477
        • Everly M.J.
        • Rebellato L.M.
        • Haisch C.E.
        • et al.
        Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
        Transplantation. 2013; 95: 410-417
        • Terasaki P.I.
        A personal perspective: 100-year history of the humoral theory of transplantation.
        Transplantation. 2012; 93: 751-756
        • Kramer C.S.M.
        • Roelen D.L.
        • Heidt S.
        • et al.
        Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.
        HLA. 2017; 90: 5-16
        • Sypek M.
        • Kausman J.
        • Holt S.
        • et al.
        HLA epitope matching in kidney transplantation: an overview for the general nephrologist.
        Am J Kidney Dis. 2017; 17: 31016-31018
        • El-Awar N.
        • Jucaud V.
        • Nguyen A.
        HLA epitopes: the targets of monoclonal and alloantibodies defined.
        J Immunol Res. 2017; 2017: 3406230
        • Lim W.H.
        • Wong G.
        • Heidt S.
        • et al.
        Novel aspects of epitope matching and practical application in kidney transplantation.
        Kidney Int. 2018; 93: 314-324
        • Bhattacharjee A.K.
        • Glaudemans C.P.
        Dual binding specificities in MOPC 384 and 870 murine myeloma immunoglobulins.
        J Immunol. 1978; 120: 411-413
        • Silverstein A.M.
        History of immunology: development of the concept of immunologic specificity: II.
        Cell Immunol. 1982; 71: 183-195
        • Silverstein A.M.
        History of immunology. Development of the concept of immunologic specificity, I.
        Cell Immunol. 1982; 67: 396-409
        • Van Regenmortel M.H.
        Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition.
        J Mol Recognit. 2014; 27: 627-639
        • Reed E.F.
        • Rao P.
        • Zhang Z.
        • et al.
        Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.
        Am J Transplant. 2013; 13: 1859-1870
        • Tambur A.R.
        • Herrera N.D.
        • Haarberg K.M.
        • et al.
        Assessing antibody strength: comparison of MFI, C1q, and titer information.
        Am J Transplant. 2015; 15: 2421-2430
        • Walsh R.C.
        • Brailey P.
        • Girnita A.
        • et al.
        Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.
        Transplantation. 2011; 91: 1218-1226
        • Richards F.F.
        • Konigsberg W.H.
        • Rosenstein R.W.
        • et al.
        On the specificity of antibodies.
        Science. 1975; 187: 130-137
        • Daga S.
        • Moyse H.
        • Briggs D.
        • et al.
        Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins.
        Hum Immunol. 2017; 79: 122-128
        • McRae B.L.
        • Vanderlugt C.L.
        • Dal Canto M.C.
        • et al.
        Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
        J Exp Med. 1995; 182: 75-85
        • Tisch R.
        • Yang X.D.
        • Singer S.M.
        • et al.
        Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
        Nature. 1993; 366: 72-75
        • Jurcevic S.
        • Ainsworth M.E.
        • Pomerance A.
        • et al.
        Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.
        Transplantation. 2001; 71: 886-892
        • Fujinami R.S.
        • Oldstone M.B.
        • Wroblewska Z.
        • et al.
        Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments.
        Proc Natl Acad Sci U S A. 1983; 80: 2346-2350
        • Cusick M.F.
        • Libbey J.E.
        • Fujinami R.S.
        Molecular mimicry as a mechanism of autoimmune disease.
        Clin Rev Allergy Immunol. 2012; 42: 102-111
        • Duquesnoy R.J.
        HLA epitope based matching for transplantation.
        Transpl Immunol. 2014; 31: 1-6
        • Bryan C.F.
        • Chadha V.
        • Warady B.A.
        Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: a new histocompatibility paradigm.
        Pediatr Transplant. 2016; 20: 926-930
        • Kausman J.Y.
        • Walker A.M.
        • Cantwell L.S.
        • et al.
        Application of an epitope-based allocation system in pediatric kidney transplantation.
        Pediatr Transplant. 2016; 20: 931-938
        • Wiebe C.
        • Pochinco D.
        • Blydt-Hansen T.D.
        • et al.
        Class II HLA epitope matching—a strategy to minimize de novo donor-specific antibody development and improve outcomes.
        Am J Transplant. 2013; 13: 3114-3122
        • Duquesnoy R.J.
        A structurally based approach to determine HLA compatibility at the humoral immune level.
        Hum Immunol. 2006; 67: 847-862
        • Duquesnoy R.J.
        • Askar M.
        HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
        Hum Immunol. 2007; 68: 12-25
        • Duquesnoy R.J.
        HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients.
        Transplant Proc. 2001; 33: 493-497
        • El-Awar N.
        • Terasaki P.I.
        • Cai J.
        • et al.
        Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
        Clin Transpl. 2009; : 295-321
        • Duquesnoy R.J.
        • Marrari M.
        • Mulder A.
        • et al.
        First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA epitope registry.
        Tissue Antigens. 2014; 83: 391-400
        • Duquesnoy R.J.
        • Marrari M.
        • Tambur A.R.
        • et al.
        First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA epitope registry.
        Hum Immunol. 2014; 75: 1097-1103
        • Kosmoliaptsis V.
        • Chaudhry A.N.
        • Sharples L.D.
        • et al.
        Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
        Transplantation. 2009; 88: 791-798
        • Kosmoliaptsis V.
        • Mallon D.H.
        • Chen Y.
        • et al.
        Alloantibody responses after renal transplant failure can be better predicted by donor-recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching.
        Am J Transplant. 2016; 16: 2139-2147
        • Kosmoliaptsis V.
        • Sharples L.D.
        • Chaudhry A.N.
        • et al.
        Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
        Transplantation. 2011; 91: 183-190
        • Otten H.G.
        • Calis J.J.
        • Kesmir C.
        • et al.
        Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
        Hum Immunol. 2013; 74: 290-296
        • Fleri W.
        • Paul S.
        • Dhanda S.K.
        • et al.
        The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design.
        Front Immunol. 2017; 8: 278
        • Larsen J.E.
        • Lund O.
        • Nielsen M.
        Improved method for predicting linear B-cell epitopes.
        Immunome Res. 2006; 2: 2
        • Parker J.M.
        • Guo D.
        • Hodges R.S.
        New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.
        Biochemistry. 1986; 25: 5425-5432
        • Emini E.A.
        • Hughes J.V.
        • Perlow D.S.
        • et al.
        Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
        J Virol. 1985; 55: 836-839
        • Pellequer J.L.
        • Van Regenmortel M.H.
        Measurement of kinetic binding constants of viral antibodies using a new biosensor technology.
        J Immunol Methods. 1993; 166: 133-143
        • Haste Andersen P.
        • Nielsen M.
        • Lund O.
        Prediction of residues in discontinuous B-cell epitopes using protein 3D structures.
        Protein Sci. 2006; 15: 2558-2567
        • Kringelum J.V.
        • Lundegaard C.
        • Lund O.
        • et al.
        Reliable B cell epitope predictions: impacts of method development and improved benchmarking.
        PLoS Comput Biol. 2012; 8: e1002829